ATE272401T1 - Heilmittel für die stenose des rückenmarkkanals - Google Patents

Heilmittel für die stenose des rückenmarkkanals

Info

Publication number
ATE272401T1
ATE272401T1 AT99940567T AT99940567T ATE272401T1 AT E272401 T1 ATE272401 T1 AT E272401T1 AT 99940567 T AT99940567 T AT 99940567T AT 99940567 T AT99940567 T AT 99940567T AT E272401 T1 ATE272401 T1 AT E272401T1
Authority
AT
Austria
Prior art keywords
spinal canal
stenosis
remedies
hydrogen atom
halogen atom
Prior art date
Application number
AT99940567T
Other languages
English (en)
Inventor
Tomoyuki Maruyama
Toru Kawamura
Toshiaki Akira
Hideaki Kido
Yoshitomimachi Koiwai
Norifumi Nakamura
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Application granted granted Critical
Publication of ATE272401T1 publication Critical patent/ATE272401T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99940567T 1998-09-01 1999-08-30 Heilmittel für die stenose des rückenmarkkanals ATE272401T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24688698 1998-09-01
PCT/JP1999/004690 WO2000012091A1 (fr) 1998-09-01 1999-08-30 Medicaments pour lutter contre la stenose du canal rachidien

Publications (1)

Publication Number Publication Date
ATE272401T1 true ATE272401T1 (de) 2004-08-15

Family

ID=17155219

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99940567T ATE272401T1 (de) 1998-09-01 1999-08-30 Heilmittel für die stenose des rückenmarkkanals

Country Status (15)

Country Link
US (1) US6369061B1 (de)
EP (1) EP1123704B1 (de)
JP (1) JP4366865B2 (de)
KR (1) KR100573376B1 (de)
CN (1) CN1137686C (de)
AT (1) ATE272401T1 (de)
AU (1) AU5445699A (de)
CA (1) CA2342198C (de)
DE (1) DE69919191T2 (de)
DK (1) DK1123704T3 (de)
ES (1) ES2221421T3 (de)
PT (1) PT1123704E (de)
RU (1) RU2229297C2 (de)
TW (1) TW544312B (de)
WO (1) WO2000012091A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070167403A1 (en) * 2003-04-03 2007-07-19 Yoshifumi Takenobu Remedy for spinal canal stenosis
CN1897952B (zh) * 2003-12-26 2010-12-08 日产化学工业株式会社 中性白细胞增多抑制剂
CN100506230C (zh) * 2004-02-09 2009-07-01 日产化学工业株式会社 血管内膜增厚抑制剂
BRPI0923556A2 (pt) 2008-12-23 2016-01-26 Pfizer agente para o tratamento de estenose do canal espinhal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79933B (de) * 1983-06-23 1984-10-31 Nissan Chemical Ind Ltd
ES2149761T3 (es) * 1990-04-25 2000-11-16 Nissan Chemical Ind Ltd Derivado de piridazinona.
JP3806945B2 (ja) 1994-01-21 2006-08-09 三菱ウェルファーマ株式会社 ヒト由来アンチトロンビン−ｉｉｉの新規用途
DK0742211T3 (da) * 1994-01-25 2000-08-14 Nissan Chemical Ind Ltd Pyridazinonderivater
IL112695A (en) 1994-02-22 1999-04-11 Green Cross Corp Pharmaceutical compositions containing pyridazinone derivatives
JPH09227411A (ja) 1996-02-26 1997-09-02 Sumitomo Pharmaceut Co Ltd 脊髄損傷による神経障害治療剤

Also Published As

Publication number Publication date
CA2342198A1 (en) 2000-03-09
DE69919191T2 (de) 2005-07-28
CN1137686C (zh) 2004-02-11
KR20010086361A (ko) 2001-09-10
RU2229297C2 (ru) 2004-05-27
US6369061B1 (en) 2002-04-09
KR100573376B1 (ko) 2006-04-25
JP4366865B2 (ja) 2009-11-18
EP1123704A4 (de) 2001-10-10
DE69919191D1 (de) 2004-09-09
PT1123704E (pt) 2004-10-29
DK1123704T3 (da) 2004-11-01
WO2000012091A1 (fr) 2000-03-09
EP1123704B1 (de) 2004-08-04
ES2221421T3 (es) 2004-12-16
CA2342198C (en) 2007-08-28
CN1325307A (zh) 2001-12-05
TW544312B (en) 2003-08-01
AU5445699A (en) 2000-03-21
EP1123704A1 (de) 2001-08-16

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
FI873631A0 (fi) --alkyl-4-amino-3-kinolinmetanoler och 1-(4-aralkylamino-3-kinolinyl)alkanoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DK0862562T3 (da) Benzoxazepinforbindelser, fremstilling deraf og anvendelse deraf som lipidniveauformindskende midler
DK0791006T3 (da) Polyanioniske benzylglylcosider som inhibitorer af proliferation af glatte muskelceller
NZ313185A (en) 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
DE60121461D1 (de) Kondensierte pyridoindolderivate
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
DE69323667D1 (de) 4-substituierte 1,2,4-Triazolderivate
AP2002002387A0 (en) Method of inhibiting amyloid aggregation and imaging amyloid deposits.
DK1847534T3 (da) Thiadiazolin-derivater til behandling af kræft
GR3003776T3 (de)
ATE272401T1 (de) Heilmittel für die stenose des rückenmarkkanals
EP1152004A4 (de) Derivate der phosphonsäure zur inhibierung von carboxypeptidase b
DE69513679D1 (de) 6-polyfluoralkoxy und 6-polyfluoralkyl-2-amino benzothiazole-derivate
EP1121932A4 (de) Heilmittel für augenerkrankungen
ATE181734T1 (de) N-benzoylmethylsubstituierte paroxetinderivate
SE9704770D0 (sv) New use
ATE238300T1 (de) (3,4-dihydro-2h-benzo(1,4)oxazinyl-methyl)-3-(1 - indol-3-yl)-alkylamine
PT1049672E (pt) Derivados de azetidinocarboxamida para o tratamento de disturbios do snc
RU2001108574A (ru) Терапевтический агент для лечения стеноза позвоночного канала
PT1049670E (pt) Derivados de azetidinocarboxamida para o tratamento de perturbacoes do snc
EP0919233B8 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen
EP1197487A4 (de) Benzimidazolderivate und sie enthaltende medikamente
ATE157874T1 (de) Mittel zur verbesserung der peripheren durchblutung
TW288015B (en) New chromene derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1123704

Country of ref document: EP